XML 17 R6.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Income (Loss) (Net of Taxes)
Balance at Dec. 31, 2023 $ 207,064 $ 62,550 $ 210,548 $ (66,034)
Balance (in shares) at Dec. 31, 2023   11,818,039    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 3,676   3,676  
Other comprehensive income 2,145     2,145
Stock issued under employee stock purchase plan (in shares)   4,380    
Stock issued under employee stock purchase plan 70 $ 70    
Stock awarded to employees (in shares)   300    
Restricted stock granted, net of forfeitures (in shares)   9,275    
Stock-based compensation expense 181 $ 181    
Cash dividend (1,419)   (1,419)  
Balance at Mar. 31, 2024 211,717 $ 62,801 212,805 (63,889)
Balance (in shares) at Mar. 31, 2024   11,831,994    
Balance at Dec. 31, 2024 362,685 $ 207,816 209,984 (55,115)
Balance (in shares) at Dec. 31, 2024   18,974,647    
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income 8,293   8,293  
Other comprehensive income 2,355     2,355
Stock issued under employee stock purchase plan (in shares)   6,642    
Stock issued under employee stock purchase plan 123 $ 123    
Restricted stock granted, net of forfeitures (in shares)   9,507    
Stock-based compensation expense 291 $ 291    
Cash dividend $ (2,278)   (2,278)  
Stock options exercised and related tax benefit (in shares) 82,042 74,343    
Stock options exercised and related tax benefit $ 808 $ 808    
Repurchase and retirement of common stock (in shares)   (4,130)    
Repurchase and retirement of common stock (80) $ (80)    
Balance at Mar. 31, 2025 $ 372,197 $ 208,958 $ 215,999 $ (52,760)
Balance (in shares) at Mar. 31, 2025   19,061,009